Advertisement

PharmacoEconomics

, Volume 9, Supplement 3, pp 34–37 | Cite as

Weekly Monitoring of Influenza Impact in Belgium (1993–1995)

  • René Snacken
Section 2: Economic Impact of Influenza

Summary

The primary objectives of an influenza monitoring programme are early detection of an epidemic and the identification of the viruses responsible. The healthcare impact ofthe disease is often some time after the epidemic. In Belgium, data on the consequences of influenza are recorded weekly, which provides an early estimate of the severity of the epidemic.

Data collected during 3 influenza seasons (1993-95) showed that during the peak of the very moderate influenza A/H3N2 outbreak in 1993-94, general practitioner consultations for acute respiratory infections increased by 100%, work absenteeism by 56%, total sales of pharmaceuticals by pharmacists by 26% and overall mortality by 14%. From these data, we estimated that 498 400 working days were lost during the peak week in Belgium in 1993, and 848 excess deaths were observed during the whole of the 1993-94 epidemic. 12% of those who died were aged less than 60 years. Hospitalisation data must be included in the future in order to complete the information that is essential for formulating public health policies on influenza vaccination.

Keywords

Influenza Adis International Limited Sickness Absence Influenza Vaccination Influenza Season 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Snacken R, Lion J, Van Casteren V, et al. Five years of sentinel surveillance of acute respiratory infections (1985-1990): the benefits of an early warning system. Eur J Epidemiol 1992; 8: 485–90PubMedCrossRefGoogle Scholar
  2. 2.
    Walckiers D, Sartor F, Snacken R. Infections respiratoires aigues et vente de medicaments. Rapport intermediaire relatifaux annees 1992 et 1993. IHE 1994. D/1994/2505/9: 34Google Scholar
  3. 3.
    Snacken R. Weekly monitoring of influenza–related mortality. Arch Publ Health 1993; 51: 28Google Scholar
  4. 4.
    Serfling RE. Methods for current statistical analysis of excess pneumonia–influenza deaths. Publ Health Rep 1963; 78: 494–506CrossRefGoogle Scholar
  5. 5.
    Chevalier A, Luce D, Goldberg M. Sickness absence at the French National Electric and Gas Company. Br J Industr Med 1987; 44: 101–10Google Scholar
  6. 6.
    Kunst AE, Looman CWN, Mackenbach JP. Deteminanten van binnenjaarlijkse fluctuaties in de sterfte [in Dutch]. Tijdschr Soc Gezond 1991; 69: 123–31Google Scholar
  7. 7.
    Ashley J, Smith T, Dunnel K. Deaths in Great Britain associated with the influenza epidemic of 1989/90. Pop Trends 1992; 65: 16–20Google Scholar
  8. 8.
    Curwen M, Dunnel K, Ashley K. Hidden influenza deaths. BMJ 1990; 300: 896Google Scholar
  9. 9.
    Monto AS. Influenza: quantifying morbidity and mortality. Am J Med 1987; 82 (S6A): 20–5PubMedCrossRefGoogle Scholar
  10. 10.
    Sprenger MJW, Diepersloot RJA, Beyer WEP, et al. Influenza related excess mortality in The Netherlands 1989-90. Lancet 1990; 336: 382PubMedCrossRefGoogle Scholar
  11. 11.
    Tillet HE, Smith JWG, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidem 1983; 12: 344–52CrossRefGoogle Scholar
  12. 12.
    Perez-Tirse J, Gross PA. Review of cost–benefit analyses of influenza vaccine. Pharmacoeconomics 1992; 2: 198–206PubMedCrossRefGoogle Scholar
  13. 13.
    Schoenbaum SC. Economic impact of influenza. The individual’s perspective. Am J Med 1987; 82 (S6A): 26–30PubMedCrossRefGoogle Scholar
  14. 14.
    Gavira FJ, Lardinois R. Cost–effectiveness analysis on influenza vaccination in a rural population (La Victoria, Cordoba) [in Spanish]. Med Clin (Bare) 1990; 94: 777–81Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • René Snacken
    • 1
  1. 1.Institute for Hygiene and EpidemiologyBelgium

Personalised recommendations